etoposide has been researched along with Leukemia, Erythroblastic, Acute in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (38.10) | 18.2507 |
| 2000's | 11 (52.38) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beneytout, JL; Bertrand, J; Ghezali, L; Leger, DY; Liagre, B | 1 |
| Creutzig, U; Dworzak, MN; Reinhardt, D; Ritter, J; Schellong, G; Zimmermann, M | 1 |
| Kadowaki, S; Kawakami, K; Watanabe, Y | 1 |
| Fouillard, L; Frassoni, F; Gorin, NC; Labopin, M; Meloni, G; Polge, E | 1 |
| Cataldi, A; Di Giacomo, V; Garaci, G; Giuseppe, F; Rana, R; Rapino, M; Sabatini, N | 1 |
| Ka, W; Sun, D; Wen, Z; Xu, X; Yao, W; Zeng, Z; Zhou, S | 1 |
| Beneytout, JL; Leger, DY; Liagre, B | 1 |
| Gilbert, GE; Heegaard, CW; Rasmussen, JT; Shi, J; Shi, Y; Waehrens, LN | 1 |
| Cheng, X; Hou, C; Jiang, H; Jin, Q; Qian, R; Xie, H; Zhang, S; Zhang, X; Zhou, W | 1 |
| Hasinoff, BB; Liang, H; Wu, X; Yalowich, JC | 1 |
| Asschert, L; de Vries, EG; van der Kolk, D; Vellenga, E; Withoff, S | 1 |
| Gantchev, TG; Kagan, VE; Stoyanovsky, DA; van Lier, JE; Yalowich, JC | 1 |
| Anachkova, B; Lallev, A; Russev, G | 1 |
| Aggarwal, BB; Gallati, H; Loetscher, H; Mihalik, R; Penzes, M; Pocsik, E | 1 |
| Russev, G; Tsvetkov, L | 1 |
| Cantori, I; Corvatta, L; Curzi, L; Leoni, P; Mancini, S; Masia, MC; Montanari, M; Olivieri, A; Poloni, A | 1 |
| Draper, MP; Levy, SB; Modrak, DE | 1 |
| Akbar, AN; Borthwick, NJ; Bravery, CA; Hart, SM; Hoffbrand, AV; Mehta, AB; Mengubas, K; Ray, N; Riordan, FA; Wickremasinghe, RG | 1 |
| Grzanka, A | 1 |
| Bown, N; Hamilton, PJ; Jackson, GH; Reid, MM; Taylor, PR; Wells, AW | 1 |
| Augery-Bourget, Y; Poindessous-Jazat, V; Robert-Lézénès, J | 1 |
1 review(s) available for etoposide and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Development of a curative treatment within the AML-BFM studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Germany; Humans; Idarubicin; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Methotrexate; Multicenter Studies as Topic; Prednisone; Randomized Controlled Trials as Topic; Survival Rate; Thioguanine; Vincristine | 2013 |
20 other study(ies) available for etoposide and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Cyclooxygenase-2 positively regulates Akt signalling and enhances survival of erythroleukemia cells exposed to anticancer agents.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Erythroblastic, Acute; Oxides; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RNA, Small Interfering; Signal Transduction; Staurosporine | 2013 |
[Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 5; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia, Erythroblastic, Acute; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Mitoguazone; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisolone; Vinblastine; Vincristine | 2003 |
Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Combinations; Etoposide; Female; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous | 2004 |
JNK/p53 mediated cell death response in K562 exposed to etoposide-ionizing radiation combined treatment.
Topics: Antineoplastic Agents, Phytogenic; Cell Death; Etoposide; Humans; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia, Erythroblastic, Acute; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Radiation, Ionizing; Tumor Suppressor Protein p53 | 2005 |
Alterations in hemorheological properties of erythrocytes in nude mice with erythroleukemia and the treatment effects of etoposide.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood Viscosity; Erythroblasts; Erythrocytes; Etoposide; Female; Hemorheology; Leukemia, Erythroblastic, Acute; Liver; Male; Mice; Mice, Nude; Neoplasms, Experimental; Spleen | 2005 |
Low dose leflunomide activates PI3K/Akt signalling in erythroleukemia cells and reduces apoptosis induced by anticancer agents.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Etoposide; Humans; Isoxazoles; K562 Cells; Leflunomide; Leukemia, Erythroblastic, Acute; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 8; NF-kappa B; Organophosphorus Compounds; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Staurosporine | 2006 |
Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death.
Topics: Annexin A5; Antigens, Surface; Apoptosis; Etoposide; Flow Cytometry; Fluorescent Dyes; HL-60 Cells; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Leukemia, Promyelocytic, Acute; Microscopy, Confocal; Milk Proteins; Phosphatidylserines | 2006 |
Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptotic Protease-Activating Factor 1; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cytochromes c; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; E2F1 Transcription Factor; Enzyme Activation; Etoposide; HeLa Cells; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Matrines; Mitochondria; Protein Transport; Quinolizines; Retinoblastoma Protein; Time Factors; Tumor Suppressor Protein p53; U937 Cells; Up-Regulation | 2007 |
A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Catalysis; CHO Cells; Cricetinae; Cricetulus; DNA; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; Etoposide; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; K562 Cells; Leukemia, Erythroblastic, Acute; Models, Chemical; Models, Molecular; Molecular Structure; Nucleic Acid Conformation; Quantitative Structure-Activity Relationship; Razoxane; Static Electricity; Topoisomerase II Inhibitors | 2008 |
VP-16-mediated cytotoxicity is modulated by interleukin-3 in a growth factor-dependent leukemic cell line.
Topics: Apoptosis; Blotting, Northern; Blotting, Western; Cell Death; DNA Topoisomerases, Type II; Etoposide; Genes, myc; Humans; Interleukin-3; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Acute; Proto-Oncogene Proteins c-myc; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation | 1994 |
Interactions of phenoxyl radical of antitumor drug, etoposide, with reductants in solution and in cell and nuclear homogenates: electron spin resonance and high-performance liquid chromatography.
Topics: Antioxidants; Ascorbic Acid; Azo Compounds; Cell Line; Cell Nucleus; Chromatography, High Pressure Liquid; Electron Spin Resonance Spectroscopy; Etoposide; Free Radicals; Glutathione; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Molecular Structure; Monophenol Monooxygenase; Phenols; Tumor Cells, Cultured | 1994 |
Effect of ionizing radiation and topoisomerase II inhibitors on DNA synthesis in mammalian cells.
Topics: Amsacrine; Animals; Carcinoma, Ehrlich Tumor; DNA; DNA Repair; DNA Replication; DNA, Mitochondrial; Etoposide; Gamma Rays; Leukemia, Erythroblastic, Acute; Mice; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1993 |
Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors.
Topics: Cell Cycle; Demecolcine; DNA; Enzyme Inhibitors; Etoposide; G1 Phase; G2 Phase; HeLa Cells; Humans; Hydroxyurea; Leukemia, Erythroblastic, Acute; Lymphoma, Large B-Cell, Diffuse; Mitosis; Nocodazole; Receptors, Tumor Necrosis Factor; S Phase; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vinblastine | 1995 |
Decreased rates of replicon initiation in mammalian cells.
Topics: Alkaloids; Animals; Antineoplastic Agents; Benzamides; Cisplatin; Cycloheximide; DNA Replication; DNA, Neoplasm; Down-Regulation; Etoposide; Friend murine leukemia virus; Kinetics; Leukemia, Erythroblastic, Acute; Mice; Replicon; Signal Transduction; Staurosporine; Tumor Cells, Cultured | 1996 |
Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide.
Topics: Antineoplastic Agents; Bone Marrow Purging; Coculture Techniques; Colony-Forming Units Assay; Cyclophosphamide; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia, Erythroblastic, Acute; Tumor Cells, Cultured | 1997 |
Emergence of different mechanisms of resistance in the evolution of multidrug resistance in murine erythroleukemia cell lines.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Daunorubicin; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Glutathione; Hydrogen-Ion Concentration; Leukemia, Erythroblastic, Acute; Mice; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured | 1997 |
Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Benzoquinones; Etoposide; Fusion Proteins, bcr-abl; Gamma Rays; HL-60 Cells; Humans; Lactams, Macrocyclic; Leukemia, Erythroblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Proto-Oncogene Proteins c-bcl-2; Quinones; Rifabutin; Tumor Cells, Cultured | 1998 |
Estimation of changes in tubulin induced with etoposide in human leukemia cells line K-562 by immunofluorescence microscope.
Topics: Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Etoposide; Humans; Leukemia, Erythroblastic, Acute; Microscopy, Fluorescence; Pseudopodia; Tubulin; Tumor Cells, Cultured | 2001 |
Erythroleukaemia in the north of England: a population based study.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Cytogenetics; Daunorubicin; England; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Leukemia, Erythroblastic, Acute; Male; Middle Aged; Prospective Studies; Risk; Survival Rate; Thioguanine; Treatment Outcome; Vidarabine | 2001 |
C-Jun modulates apoptosis but not terminal cell differentiation in murine erythroleukemia cells.
Topics: Animals; Anisomycin; Antibiotics, Antineoplastic; Apoptosis; Cell Differentiation; Culture Media, Serum-Free; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Daunorubicin; Dimethyl Sulfoxide; DNA, Antisense; Enzyme Activation; Enzyme Inhibitors; Etoposide; Gene Expression Regulation, Leukemic; Genes, jun; JNK Mitogen-Activated Protein Kinases; Leukemia, Erythroblastic, Acute; Mice; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphorylation; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-jun; Recombinant Fusion Proteins; Topoisomerase II Inhibitors; Transfection; Tumor Cells, Cultured | 2002 |